Contact
🔒 Contacts are masked. Get full emails & phones. Unlock via export ↗
Category
Primary
biotech-and-biomedical-industry · embed-ft 0.54
Tree path
Business and Finance › Industries › Biotech and Biomedical Industry
Group (tier-1)
Tech stack
AI readiness
AI training policy
allowed
Terms of Service
AI-bot protection
AI files
llms.txt ai.txt humans.txt robots.txt
Compliance (GEO / GDPR)
TLD
Overview
Title
ONCOdianova - The Future of Biomarkers - TIGIT / CD112R / CALRmut
Description
ONCOdianova - The Future of Biomarkes - TIGIT / CD112R / CALRmut. ONCOdianova‘s antibody development program concentrates on the tissue-based detection of cancer immunology checkpoint biomarkers. Our vision is to provide the best primary antibodies for combined use in multiplex IHC panels.
Final URL
Language
en (html)
Scanned at
2026-06-25 14:02:02